Home LiteratureArticle Details
PMID: 16608535 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone.

Breast cancer research : BCR ·Vol. 8 ·No. 2 ·2006-00-00 ·Pages R20

Sloan EK, Pouliot N, Stanley KL, Chia J, Moseley JM, Hards DK, Anderson RL

Abstract

Studies in xenograft models and experimental models of metastasis have implicated several beta3 integrin-expressing cell populations, including endothelium, platelets and osteoclasts, in breast tumor progression. Since orthotopic human xenograft models of breast cancer are poorly metastatic to bone and experimental models bypass the formation of a primary tumor, however, the precise contribution of tumor-specific alphavbeta3 to the spontaneous metastasis of breast tumors from the mammary gland to bone remains unclear. We used a syngeneic orthotopic model of spontaneous breast cancer metastasis to test whether exogenous expression of alphavbeta3 in a mammary carcinoma line (66cl4) that metastasizes to the lung, but not to bone, was sufficient to promote its spontaneous metastasis to bone from the mammary gland. The tumor burden in the spine and the lung following inoculation of alphavbeta3-expressing 66cl4 (66cl4beta3) tumor cells or control 66cl4pBabe into the mammary gland was analyzed by real-time quantitative PCR. The ability of these cells to grow and form osteolytic lesions in bone was determined by histology and tartrate-resistant acid phosphatase staining of bone sections following intratibial injection of tumor cells. The adhesive, migratory and invasive properties of 66cl4pBabe and 66cl4beta3 cells were evaluated in standard in vitro assays. The 66cl4beta3 tumors showed a 20-fold increase in metastatic burden in the spine compared with 66cl4pBabe. A similar trend in lung metastasis was observed. alphavbeta3 did not increase the proliferation of 66cl4 cells in vitro or in the mammary gland in vivo. Similarly, alphavbeta3 is not required for the proliferation of 66cl4 cells in bone as both 66cl4pBabe and 66cl4beta3 proliferated to the same extent when injected directly into the tibia. 66cl4beta3 tumor growth in the tibia, however, increased osteoclast recruitment and bone resorption compared with 66cl4 tumors. Moreover, alphavbeta3 increased 66cl4 tumor cell adhesion and alphavbeta3-dependent haptotactic migration towards bone matrix proteins, as well as their chemotactic response to bone-derived soluble factors in vitro. These results demonstrate for the first time that tumor-specific alphavbeta3 contributes to spontaneous metastasis of breast tumors to bone and suggest a critical role for this receptor in mediating chemotactic and haptotactic migration towards bone factors.

MeSH Terms
Animals Bone Neoplasms/pathology,secondary Breast Neoplasms/pathology Cell Adhesion Cell Division Cell Line Epithelial Cells/cytology,pathology Female Humans Integrin alphaVbeta3/physiology Mammary Glands, Animal/cytology Mice Neoplasm Metastasis Spinal Neoplasms/pathology,secondary
Chemicals
Integrin alphaVbeta3
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Sloan Erica K
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Pouliot Normand
Stanley Kym L
Chia Jenny
Moseley Jane M
Hards Daphne K
Anderson Robin L
References (61)
61 references, click to expand
  1. Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-alphav integrin regulates cross-talk between alphavbeta3 and alpha2beta1 integrins in breast carcinoma cells.
    Exp Cell Res. 2003 Nov 15;291(1):167-75 PMID: 14597417
  2. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression.
    Anticancer Res. 2005 Jan-Feb;25(1A):79-83 PMID: 15816522
  3. Adhesion and migration of extracellular matrix-stimulated breast cancer.
    J Surg Res. 2003 Mar;110(1):287-94 PMID: 12697413
  4. Integrin signaling.
    Science. 1999 Aug 13;285(5430):1028-32 PMID: 10446041
  5. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone.
    FASEB J. 2002 Aug;16(10):1266-8 PMID: 12153995
  6. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.
    Int J Cancer. 2000 Apr 1;86(1):15-23 PMID: 10728589
  7. Laminin 10/11: an alternative adhesive ligand for epidermal keratinocytes with a functional role in promoting proliferation and migration.
    Exp Dermatol. 2002 Oct;11(5):387-97 PMID: 12366691
  8. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
    Clin Cancer Res. 2005 Jan 1;11(1):306-14 PMID: 15671560
  9. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
    J Clin Invest. 1995 Oct;96(4):1815-22 PMID: 7560073
  10. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells.
    Exp Cell Res. 2001 Feb 15;263(2):209-23 PMID: 11161720
  11. Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins.
    Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):763-8 PMID: 14718670
  12. Prinomastat, a hydroxamate inhibitor of matrix metalloproteinases, has a complex effect on migration of breast carcinoma cells.
    Int J Cancer. 2003 May 1;104(5):533-41 PMID: 12594807
  13. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
    Mol Cancer Res. 2005 Jan;3(1):1-13 PMID: 15671244
  14. Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases.
    Clin Exp Metastasis. 2003;20(5):413-20 PMID: 14524530
  15. Adhesion events in angiogenesis.
    Curr Opin Cell Biol. 2001 Oct;13(5):563-8 PMID: 11544024
  16. Development of skeletal metastases.
    Clin Orthop Relat Res. 1995 Mar;(312):45-50 PMID: 7634617
  17. Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas.
    Int J Cancer. 1997 May 2;71(3):320-4 PMID: 9139861
  18. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
    Mol Cancer Res. 2003 Sep;1(11):810-9 PMID: 14517343
  19. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells.
    J Biol Chem. 1996 Feb 2;271(5):2443-7 PMID: 8576205
  20. Platelet and osteoclast beta3 integrins are critical for bone metastasis.
    Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14205-10 PMID: 14612570
  21. Integrin activation controls metastasis in human breast cancer.
    Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1853-8 PMID: 11172040
  22. Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibody of c7E3 Fab (abciximab; ReoPro).
    Angiogenesis. 1999;3(1):53-60 PMID: 14517444
  23. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
    Nat Med. 2002 Jan;8(1):27-34 PMID: 11786903
  24. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
    J Cell Physiol. 1998 Sep;176(3):482-94 PMID: 9699501
  25. Mechanisms of osteolytic bone metastases in breast carcinoma.
    Cancer. 2003 Feb 1;97(3 Suppl):834-9 PMID: 12548583
  26. Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components.
    Lab Invest. 1997 Dec;77(6):665-75 PMID: 9426405
  27. The role of alpha(v)beta(3) in prostate cancer progression.
    Neoplasia. 2002 May-Jun;4(3):191-4 PMID: 11988838
  28. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
    Clin Cancer Res. 1998 Nov;4(11):2625-34 PMID: 9829725
  29. Genes involved in breast cancer metastasis to bone.
    Cell Mol Life Sci. 2002 Sep;59(9):1491-502 PMID: 12440771
  30. Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase.
    J Biol Chem. 2002 Mar 22;277(12):9749-56 PMID: 11724803
  31. A novel orthotopic model of breast cancer metastasis to bone.
    Clin Exp Metastasis. 1999 Mar;17(2):163-70 PMID: 10411109
  32. Role of stromal-derived cytokines and growth factors in bone metastasis.
    Cancer. 2003 Feb 1;97(3 Suppl):733-8 PMID: 12548570
  33. Clinical course and prognostic factors following bone recurrence from breast cancer.
    Br J Cancer. 1998;77(2):336-40 PMID: 9461007
  34. A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.
    Clin Exp Metastasis. 2004;21(2):119-28 PMID: 15168729
  35. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
    J Clin Invest. 2004 Dec;114(12):1714-25 PMID: 15599396
  36. Adherence to osteopontin via alphavbeta3 suppresses phorbol ester-mediated apoptosis in MCF-7 breast cancer cells that overexpress protein kinase C-alpha.
    Int J Oncol. 2000 Dec;17(6):1237-43 PMID: 11078811
  37. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.
    Clin Exp Metastasis. 2002;19(5):427-36 PMID: 12198771
  38. Integrin alpha V beta 3 expression by bone-residing breast cancer metastases.
    Diagn Mol Pathol. 1996 Jun;5(2):127-35 PMID: 8727100
  39. Alphav integrins mediate adhesion and migration of breast carcinoma cell lines.
    Clin Exp Metastasis. 1998 Jan;16(1):50-61 PMID: 9502077
  40. Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain.
    J Biol Chem. 2000 Dec 22;275(51):39867-73 PMID: 10964931
  41. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells.
    Nucleic Acids Res. 1990 Feb 25;18(4):1068 PMID: 2156225
  42. MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.
    Clin Exp Metastasis. 2000;18(7):553-60 PMID: 11688960
  43. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
    Cancer Res. 1993 Mar 15;53(6):1421-30 PMID: 7680285
  44. The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration.
    J Cell Sci. 1998 Feb;111 ( Pt 4):469-78 PMID: 9443896
  45. Requirement of vascular integrin alpha v beta 3 for angiogenesis.
    Science. 1994 Apr 22;264(5158):569-71 PMID: 7512751
  46. Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: effects of alphavbeta3 and alphaIIbbeta3 antagonists.
    Clin Exp Metastasis. 2004;21(6):553-61 PMID: 15679053
  47. Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors.
    J Mammary Gland Biol Neoplasia. 1998 Apr;3(2):191-200 PMID: 10819527
  48. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.
    Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9482-7 PMID: 12874388
  49. Inhibitors of integrins.
    Curr Opin Pharmacol. 2002 Aug;2(4):394-402 PMID: 12127872
  50. Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression.
    Breast Cancer Res Treat. 2000 Jun;61(3):249-60 PMID: 10966001
  51. Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast.
    Br J Cancer. 1997;75(2):221-9 PMID: 9010030
  52. Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo.
    Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):119-24 PMID: 11134507
  53. Involvement of chemokine receptors in breast cancer metastasis.
    Nature. 2001 Mar 1;410(6824):50-6 PMID: 11242036
  54. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.
    Cancer Res. 1992 Mar 15;52(6):1399-405 PMID: 1540948
  55. Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth.
    Cancer Res. 2004 Feb 1;64(3):977-84 PMID: 14871828
  56. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
    Cancer Res. 1999 Jan 1;59(1):241-8 PMID: 9892213
  57. The clinical course of bone metastases from breast cancer.
    Br J Cancer. 1987 Jan;55(1):61-6 PMID: 3814476
  58. Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme.
    Cancer Res. 2004 Apr 15;64(8):2751-8 PMID: 15087390
  59. Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF.
    EMBO J. 1997 Sep 15;16(18):5600-7 PMID: 9312019
  60. Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors.
    Hum Pathol. 1992 Oct;23(10):1159-66 PMID: 1383121
  61. Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247.
    Clin Exp Metastasis. 2004;21(2):129-38 PMID: 15168730
Article Info
Journal
Breast cancer research : BCR
Abbr.
Breast Cancer Res
ISSN
1465-542X
Published
2006-00-00
Epub
2006-00-11
Pages
R20
Language
English
Region
England
NLM ID
100927353
PMCID
PMC1557720
Subset
IM
Grants
NCI NIH HHS · R01 CA090291 · United States
NCI NIH HHS · R0I CA 90291 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com